Genetic manipulation of insulin action and β-cell function in mice

Molecular and Cellular Biochemistry

Volumn 182, Issue 1-2, 1998, Pages 161-168

  Lamothe, Betty ^a   Duvillié, Bertrand ^a   Cordonnier, Nathalie ^a   Baudry, Anne ^a   Saint Just, Susan ^a   Bucchini, Danielle ^a   Jami, Jacques ^a   Joshi, Rajiv L ^a,b  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

Author keywords

Animal models; Knockout mice; NIDDM; Transgenic mice

Indexed keywords

AMYLIN; GLUCOKINASE; GLYCOGEN SYNTHASE; HEXOKINASE; INSULIN; INSULIN RECEPTOR; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP);

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; GENE TARGETING; GENETIC MANIPULATION; KNOCKOUT MOUSE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; TRANSGENIC MOUSE;

ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HUMANS; INSULIN; ISLETS OF LANGERHANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC;

ANIMALIA; MUS MUSCULUS;

EID: 0031917630     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006813712567     Document Type: Article

References (71)

1. Moller DE, Bjorbaek C, Vidai-Pulg A: Candidate genes for insulin resistance. Diabetes Care 19: 396-400, 1996
2. Shuldiner AR, Silver KD: Candidate genes in non-insulin dependent diabetes mellitus. In: D LeRoith, JM Olelfsky, SI Taylor, (eds). Diabetes Mellitus: A Fundamental and Clinical Text. Lippincott, in press
3. Kahn CR: Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43: 1066-1084, 1994
4. De Meyts P: The diabetogenes concept of NIDDM. Adv Exp Med Biol 334: 89-100, 1993
5. Shafrir E: Animal models of non-insulin dependent diabetes. Diabetes Metab Rev 8: 179-208, 1992
6. Joshi RL, Lamothe B, Cordonnier N, Mesbah K, Monthioux E, Jami J, Bucchini D: Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J 15: 1542-1547, 1996
7. Moller DE: Transgenic approaches to the pathogenesis of NIDDM. Diabetes 43: 1394-1401, 1994
8. Bronson SK, Smithies O: Altering mice by homologous recombination using embryonic stem cells. J Biol Chem 269: 27155-27158, 1994
9. Benecke H, Flier JS, Rosenthal N, Siddle K, Klein HH, Moller DE: Muscle-specific expression of human insulin receptor in transgenic mice. Diabetes 42: 206-212, 1993
10. Nishiyama T, Shirotani T, Murakami T, Shimada F, Todaka M, Saito S, Hayashi H, Noma Y, Shima K, Makino H, Shichiri M, Miyazaki JI, Yamamura KI, Ebina Y: Expression of the gene encoding the tyrosine kinase-deficient human insulin receptor in transgenic mice. Gene 141: 187-192, 1994
11. Chang PY, Benecke H, Le Marchand-Brustel Y, Lawitts J, Moller DE: Expression of a dominant-negative mutant human insulin receptor in the muscle of transgenic mice. J Biol Chem 269: 16034-16040, 1994
12. Moller DE, Chang PY, Yaspelkis BB III, Flier JS, Wallberg-Henriksson H, Ivy JL: Transgenic mice with muscle-specific insulin resistance develop increased adiposity, impaired glucose tolerance, and dyslipidemia. Endocrinol, in press
13. Chang PY, Goodyear W, Benecke H, Markuns JS, Moller DE: Impaired insulin signaling in skeletal muscles from transgenic mice expressing kinase-deficient insulin receptors. J Biol Chem 270: 12593-12600, 1995
14. rsk, and p70 S6 kinase in skeletal muscle of normal and insulin-resistant mice. J Biol Chem 270: 29928-29935, 1995
15. Schaefer EM, Viard V, Morin J, Ferré P, Pénicaud L, Ramos P, Maika SD, Ellis L, Hammer RE: A new transgenic mouse model of chronic hyperglycemia. Diabetes 43: 143-153, 1994
16. Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, Asico LD, José PA, Taylor SI, Westphal H: Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nature Genet 12: 106-109, 1996
17. De Meyts P, Wallach B, Christoffersen CT, Urso B, Gronskov K, Latus W, Yakushiji F, Hondo MM, Shymko RM: The insulin-like growth factor-1 receptor. Horm Res 42: 152-169, 1994
18. DeChiara TM, Efstratiadis A, Robertson EJ: A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345: 78-80, 1990
19. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A: Mice carrying null mutations of the genes encoding insulin-like growth fact or I (igf-1) and type 1 IGF receptor (igf- 1r). Cell 75: 59-72, 1993
20. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA: IGF-1 is required for normal embryonic growth in mice. Genes Dev 7: 2609-2617, 1993
21. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburaji Y, Satoh S, Sekihara H, Yoshioka S, Horikoshi H, Furuta Y, Ikawa Y, Kasuga M, Yazaki Y Aizawa S: Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372: 182-186, 1994
22. Araki E, Lipes MA, Patti ME, Brüning JC, Haag B III, Johnson RS, Kahn CR: Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-1 gene. Nature 372: 186-190, 1994
23. Chang PY, Jensen J, Printz RL, Granner DK, Ivy JL, Moller DE: Overexpression of hexokinase II in transgenic mice: Evidence that increased phosphorylation augments muscle glucose uptake. J Biol Chem, in press
24. Ezaki O, Flores-Riveros JR, Kaestner KH, Gearhart J, Lane MD: Regulated expression of an insulin-responsive glucose transporter (GLUT4) minigene in 3T3-L1 adipocytes and transgenic mice. Proc Natl Acad Sci USA 90: 3348-3352, 1993
25. Olson AL, Liu ML, Moye-Rowley WS, Buse JB, Bell GI, Pessin JE: Hormonal/metabolic regulation of the human GLUT4/muscle-fat facilitative glucose transporter gene in transgenic mice. J Biol Chem 268: 9839-9846, 1993
26. Deems RO, Evans JL, Deacon RW, Honer CM, Chu DT, Bürki K, Fillers WS, Cohen DK, Young DA: Expression of human GLUT4 in mice results in increased insulin action. Diabetologia 37: 1097-1104, 1994
27. Marshall B A, Mueckler MM: Differential effects of GLUT1 or GLUT4 overexpression on insulin responsiveness in transgenic mice. Am J Physiol 267: E738-E744, 1994
28. Treadway JL, Hargrove DM, Nardone NA, McPherson RK, Russo JF, Milici AJ, Stukenbrok HA, Gibbs EM, Stevenson RW, Pessin JE: Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene. J Biol Chem 269: 29956-29961, 1994
29. Hansen PA, Gulve EA, Marshall BA, Gao J, Pessin JE, Holloszy JO, Mueckler M: Skeletal muscle glucose transport and metabolism are enhanced in transgenic mice overexpressing the GLUT4 glucose transporter. J Biol Chem 270: 1679-1684, 1995
30. Ikemoto S, Thompson KS, Itakura H, Lane MD, Ezaki O: Expression of an insulin responsive glucose transporter (GLUT4) minigene in transgenic mice: Effect of exercise and role in glucose homeostasis. Proc Natl Acad Sci USA 92: 865-869, 1995
31. Ren JM, Marshall BA, Mueckler MM, McCaleb M, Amatruda JM, Shulman GI: Overexpression of GLUT4 protein in muscle increase basal and insulin-stimulated whole body glucose disposal in conscious mice. J Clin Invest 95: 429-432, 1995
32. Ikemoto S, Thompson KS, Takahashi M, Itakura H, Lane MD, Ezaki O: High fat diet induced hyperglycemia: Prevention by low level expression of glucose transporter (GLUT4) minigene in transgenic mice. Proc Natl Acad Sci USA 92: 3096-3099, 1995
33. Gibbs EM, Stock JL, McCoid SC, Stukenbrok HA, Pessin JE, Stevenson RW, Milici AJ, McNeish JD: Glycemic improvement in diabeticdb/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). J Clin Invest 95: 1512-1518, 1995
34. Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB: Adipose cell hyperplysia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 268: 22243-22246, 1993
35. Gnudi L, Tozzo E, Shepherd PR, Bliss JL, Kahn BB: High level overexpression of glucose transporter-4 driven by an adipose-specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance. Endocrinol 136: 995-1002, 1995
36. Tsao TS, Burcelin R, Katz EB, Huang L, Charron MJ: Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes 45: 28-36, 1996
37. Leturque A, Loizeau M, Vaulont S, Salminen M, Girard J: Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle. Diabetes 45: 23-27, 1996
38. Marshall BA, Ren JM, Johnson DW, Gibbs EM, Liliquist JS, Soeller WC, Holloszy JO, Mueckler M: Germline manipulation of glucose homeostasis via alteration of glucose transporter levels in skeletal muscle. J Biol Chem 268: 18442-18445, 1993
39. Ren JM, Marshall BA, Gulve EA, Gao J, Johnson DW, Holloszy JO, Mueckler M: Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle. J Biol Chem 268: 16113-16115, 1993
40. Gulve EA, Ren JM, Marshall BA, Gao J, Hansen PA, Holloszy JO, Mueckler M: Glucose transport activity in skeletal muscles from transgenic mice overexpressing GLUT 1. J Biol Chem 269: 18366-18370, 1994
41. Katz EB, Stenbit AK, Hatton K, DePinho R, Charron MJ: Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 377: 151-155, 1995
42. Valera A, Pujol A, Pelegrin M, Bosch F: Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91: 9151-9154, 1994
43. Manchester J, Skurat AV, Roach P, Hauschka SD, Lawrence JR JC: Increased glycogen accumulation in transgenic mice overexpressing glycogen synthetase in skeletal muscle. Proc Natl Acad Sci USA 93: 10707-10711, 1996
44. Ferre T, Pujol A, Riu E, Bosch F, Valera A: Correction of diabetic alterations by glucokinase. Proc Natl Acad Sci USA 93: 7225-7230, 1996
45. iα2. Nature 379: 840-844, 1996
46. Ross SR, Graves RA, Spiegelman BM: Targeted expression of a toxin gene to adipose tissue: Transgenic mice resistant to obesity. Genes Dev 7: 1318-1324, 1993
47. Lowell BB, Susulic VS, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, Kozak LP, Flier JS: Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366: 740-742, 1993
48. Hamann A, Benecke H, Le Marchand-Brustel Y, Susulic VS, Lowell BB, Flier JS: Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat. Diabetes 44: 1266-1273, 1995
49. Kozak LP, Kozak UC, Clarke GT: Abnormal brown and white fat development in transgenic mice overexpressing glycerol 3-phosphate dehydrogenase. Genes Dev 5: 2256-2264, 1991
50. IIβ subunit of protein kinase A. Nature 382: 622-626, 1996
51. Taylor SI, Accili D, Imai Y: Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes 43: 735-740, 1994
52. Bucchini D, Ripoche M-A, Stinnakre M-G, Desbois P, Lorès P, Monthioux E, Absil J, Lepesant J-A, Pictet R, Jami J: Pancreatic expression of human insulin gene in transgenic mice. Proc Natl Acad Sci USA 83: 2511-2515, 1986
53. Selden RF, Skoskiewicz MJ, Howie KB, Russell PS, Goodman HM: Regulation of human insulin gene expression in transgenic mice. Nature 321: 525-528, 1986
54. Schnetzler B, Murakawa G, Abalos D, Halban P, Selden R: Adaptation to supraphysiologic levels of insulin gene expression in transgenic mice: evidence for the importance of post-transcriptional regulation. J Clin Invest 92: 272-280, 1993
55. Marban SL, DeLoia JA, Gearhart JD: Hyperinsulinemia in transgenic mice carrying multiple copies of the human insulin gene. Develop Genet 10: 356-364, 1989
56. Carroll RJ, Hammer RE, Chan SJ, Swift HH, Rubenstein AH, Steiner DF: A mutant human proinsulin is secreted from islets of Langherans in increased amounts via an unregulated pathway. Proc Natl Acad Sci USA 85: 8943-8947, 1988
57. Ma YH, Lorès P, Wang J, Jami J, Grodsky GM: Constitutive (pro)insulin release from pancreas of transgenic mice expressing monomeric insulin. Endocrinol 136: 2622-2630, 1995
58. Efrat S, Leiser M, Wu YJ, Fusco-DeMane D, Emran OA, Surana M, Jetton TL, Magnuson MA, Weir G, Fleischer N: Ribozyme-mediated attenuation of pancreatic β-cell glucokinase expression in transgenic mice results in impaired glucose-induced insulin secretion. Proc Natl Acad Sci USA 91: 2051-2055, 1994
59. Ishihara H, Tashiro F, Ikuta K, Asano T, Katagiri H, Inukai K, Kikuchi M, Yazaki Y, Oka Y, Miyazaki JI: Inhibition of pancreatic β-cell glucokinase by antisense RNA expression in transgenic mice: mouse strain-dependent alteration of glucose tolerance. FEBS Lett 371: 329-332, 1995
60. Epstein PN, Boschero AC, Atwater I, Cai X, Overbeek PA: Expression of yeast hexokinase in pancreatic β-cells of transgenic mice reduces blood glucose, enhances insulin secretion, and decreases diabetes. Proc Natl Acad Sci USA 89: 12038-12042, 1992
61. Voss-McCowan ME, Bonner-Weir S, Klevay LM, Epstein PN: A yeast hexokinase transgene decreases pancreatic insulin and transiently reduces diabetes. 1: 103-111, 1993
62. Epstein PN, Overbeek PA, Means AR: Calmodulin-induced early-onset diabetes in transgenic mice. Cell 58: 1067-1073, 1989
63. Grupe A, Hultgren B, Ryan A, Ma YH, Bauer M, Stewart TA: Transgenic knockouts reveal a critical requirement for pancreatic β-cell glucokinase in maintaining glucose homeostasis. Cell 83: 69-78, 1995
64. Terauchi Y, Sakura H, Yasuda K, Iwamoto K, Takahashi N, Ito K, Kasai H, Suzuki H, Ueda O, Kamada N, Jishage K, Komeda K, Noda M, Kanazawa Y Taniguchi S, Miwa I, Akanuma Y Kodama T, Yazaki Y, Kadowaki T: Pancreatic β-cell-specific targeted disruption of glucokinase gene. J Biol Chem 270: 30253-30256, 1995
65. Bali D, Svetlanov A, Lee HW, Fusco-DeMane D, Leiser M, Li B, Barzilai N, Surana M, Hou H, Fleischer N, DePinho R, Rossetti L, Efrat S: Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene. J Biol Chem 270: 21464-21467, 1995
66. Valera A, Solanes G, Fernandez-Alvarez J, Pujol A, Ferrer J, Asins G, Gomis R, Bosch F: Expression of GLUT2 antisense RNA in β-cells of transgenic mice leads to diabetes. J Biol Chem 269: 28543-28546, 1994
67. 12]HRAS downregulates GLUT2 in β-cells of transgenic mice without affecting glucose homeostasis. Proc Natl Acad Sci USA 89: 5744-5748, 1992
68. Yagui K, Yamaguchi T, Kanatsuka A, Shimada F, Huang CI, Tokuyama Y, Ohsawa H, Yamamura KI, Miyazaki JI, Mikata A, Yoshida S, Makino H: Formation of islet amyloid fibrils in beta-secretory granules of transgenic mice expressing human islet amyloid polypeptide/amylin. Eur J Endocrinol 132: 487-496, 1995
69. Fox N, Schrementi J, Nishi M, Ohagi S, Chan SJ, Heisserman JA, Westermark GT, Leckström A, Westermark P, Steiner DF: Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM). FEBS Lett 323: 40-44, 1993
70. Höppener JW, Oosterwijk C, van Hulst KL, Verbeek JS, Capel PJ, de Koning EJ, Clark A, Jansz HS, Lips CJ: Molecular physiology of the islet amyloid polypeptide (IAPP)/amylin gene in man, rat, and transgenic mice. J Cell Biochem 55: 39-53, 1994
71. de Koning EJP, Höppener JWM, Verbeek JS, Oosterwijk C, van Hulst KL, Baker CA, Lips CJM, Morris JF, Clark A: Human islet amyloid polypeptide accumulates at similar sites in islets of transgenic mice and humans. Diabetes 43: 640-644, 1994